Scarica l'app Stockscreener
57.77
1.80%
1.02
Dopo l'orario di chiusura:
57.77
Precedente Chiudi:
$56.75
Aprire:
$56.64
Volume 24 ore:
1.43M
Relative Volume:
0.67
Capitalizzazione di mercato:
$11.09B
Reddito:
$2.95B
Utile/perdita netta:
$523.88M
Rapporto P/E:
21.48
EPS:
2.69
Flusso di cassa netto:
$620.18M
1 W Prestazione:
-0.86%
1M Prestazione:
-6.72%
6M Prestazione:
-18.85%
1 anno Prestazione:
-32.13%
Intervallo 1D:
$56.58
$58.03
Intervallo di 1 settimana:
$55.99
$59.79
Portata 52W:
$52.93
$86.04
Biomarin Pharmaceutical Inc Stock (BMRN) Company Profile
Nome
Biomarin Pharmaceutical Inc
Settore
Industria
Telefono
(415) 506-6700
Indirizzo
105 DIGITAL DRIVE, NOVATO, CA
Confronta BMRN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BMRN
Biomarin Pharmaceutical Inc
|
57.77 | 10.90B | 2.95B | 523.88M | 620.18M | 2.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Biomarin Pharmaceutical Inc Stock (BMRN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-03 | Iniziato | Raymond James | Outperform |
| 2025-07-03 | Ripresa | Morgan Stanley | Overweight |
| 2025-02-24 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2024-11-15 | Iniziato | Wolfe Research | Outperform |
| 2024-10-30 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-10-10 | Ripresa | Raymond James | Outperform |
| 2024-08-20 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-05-17 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-05-14 | Iniziato | Evercore ISI | Outperform |
| 2023-11-15 | Iniziato | Wells Fargo | Overweight |
| 2023-10-23 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2023-09-28 | Iniziato | Raymond James | Mkt Perform |
| 2023-09-18 | Iniziato | UBS | Buy |
| 2023-07-27 | Iniziato | Scotiabank | Sector Perform |
| 2023-07-05 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-06-14 | Ripresa | Credit Suisse | Outperform |
| 2023-03-21 | Iniziato | Bernstein | Underperform |
| 2023-02-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2023-02-21 | Iniziato | Citigroup | Neutral |
| 2023-01-30 | Iniziato | BMO Capital Markets | Market Perform |
| 2023-01-18 | Iniziato | Canaccord Genuity | Hold |
| 2022-10-31 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2022-07-13 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-06-13 | Ripresa | Wedbush | Neutral |
| 2022-04-25 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-11-22 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2021-10-07 | Ripresa | Jefferies | Buy |
| 2021-09-09 | Aggiornamento | Stifel | Hold → Buy |
| 2021-06-04 | Ripresa | Robert W. Baird | Outperform |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-03-04 | Ripresa | Guggenheim | Buy |
| 2021-03-01 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-08-20 | Downgrade | Citigroup | Buy → Neutral |
| 2020-08-20 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2020-08-19 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-08-19 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-08-19 | Downgrade | Stifel | Buy → Hold |
| 2020-07-08 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-07-06 | Reiterato | Citigroup | Buy |
| 2020-01-28 | Iniziato | BMO Capital Markets | Market Perform |
| 2020-01-27 | Iniziato | BMO Capital Markets | Market Perform |
| 2020-01-24 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-11-27 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2019-11-12 | Iniziato | SunTrust | Buy |
| 2019-10-17 | Ripresa | BofA/Merrill | Buy |
| 2019-05-23 | Ripresa | Citigroup | Buy |
| 2019-04-09 | Ripresa | Raymond James | Outperform |
| 2019-01-02 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2018-12-14 | Iniziato | Wolfe Research | Outperform |
| 2018-10-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-08-07 | Reiterato | Stifel | Buy |
| 2018-08-03 | Reiterato | Stifel | Buy |
Mostra tutto
Biomarin Pharmaceutical Inc Borsa (BMRN) Ultime notizie
What makes BioMarin Pharmaceutical Inc. stock price move sharply2025 Pullback Review & AI Driven Stock Reports - Newser
Is BioMarin Pharmaceutical Inc. stock influenced by commodity prices2025 Bull vs Bear & Detailed Earnings Play Strategies - خودرو بانک
What’s the outlook for BioMarin Pharmaceutical Inc.’s sector2025 Sector Review & Fast Moving Trade Plans - خودرو بانک
BioMarin Pharmaceutical Inc. stock daily chart insightsWeekly Trade Analysis & Verified Trade Idea Suggestions - Newser
How to use a screener to detect BioMarin Pharmaceutical Inc. breakoutsJuly 2025 Technicals & Verified Entry Point Signals - Newser
Analyzing drawdowns of BioMarin Pharmaceutical Inc. with statistical toolsRate Cut & Low Risk Investment Opportunities - Newser
Tick level data insight on BioMarin Pharmaceutical Inc. volatilityJuly 2025 PostEarnings & Technical Pattern Alert System - Newser
BioMarin at Wells Fargo Conference: Strategic Focus on Rare Diseases - Investing.com
What machine learning models say about BioMarin Pharmaceutical Inc.Earnings Risk Summary & High Accuracy Buy Signal Tips - Newser
Will BioMarin Pharmaceutical Inc. bounce back from current supportJuly 2025 Action & Community Consensus Picks - Newser
Visual trend scoring systems applied to BioMarin Pharmaceutical Inc.2025 Year in Review & Technical Confirmation Trade Alerts - Newser
Technical signs of recovery in BioMarin Pharmaceutical Inc.July 2025 Closing Moves & Free Safe Entry Trade Signal Reports - Newser
Will BioMarin Pharmaceutical Inc. price bounce be sustainableMarket Performance Recap & Real-Time Sentiment Analysis - Newser
Top chart patterns to watch in BioMarin Pharmaceutical Inc.Take Profit & Risk Adjusted Buy/Sell Alerts - Newser
What Does Wall Street Think About BioMarin Pharmaceutical (BMRN)? - MSN
BioMarin Pharmaceutical shares fall 1.15% after-hours following analyst presentation at Cantor Global. - AInvest
BioMarin (BMRN) Down 4.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
BioMarin’s Strategic Position in the 2025 Healthcare Innovation Landscape - AInvest
Will BioMarin Pharmaceutical Inc. outperform small cap indexesPortfolio Update Report & Stock Market Timing Techniques - خودرو بانک
Can you recover from losses in BioMarin Pharmaceutical Inc.2025 AllTime Highs & Safe Capital Growth Trade Ideas - Newser
Intraday pattern recognizer results for BioMarin Pharmaceutical Inc.2025 Top Decliners & Verified Swing Trading Watchlist - Newser
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed? - 富途牛牛
Should I invest in BioMarin Pharmaceutical Inc. before earningsTrade Risk Assessment & AI Forecast Swing Trade Picks - خودرو بانک
Combining price and volume data for BioMarin Pharmaceutical Inc.Weekly Trend Summary & Risk Managed Investment Strategies - Newser
Applying Wyckoff theory to BioMarin Pharmaceutical Inc. stockWeekly Gains Report & Real-Time Market Sentiment Alerts - Newser
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock - Yahoo Finance
Should you wait for a breakout in BioMarin Pharmaceutical Inc.Trade Analysis Summary & AI Optimized Trade Strategies - Newser
Can you recover from losses in BioMarin Pharmaceutical IncJuly 2025 Volume & Real-Time Stock Price Movement Reports - Newser
What moving averages say about BioMarin Pharmaceutical Inc.2025 Bull vs Bear & Expert-Curated Trade Recommendations - Newser
Identifying reversal signals in BioMarin Pharmaceutical Inc.July 2025 Institutional & Weekly Top Performers Watchlists - Newser
Is BioMarin Pharmaceutical Inc. stock poised for growthMarket Growth Summary & Weekly Setup with High ROI Potential - Newser
Elliott Wave Theory Predicts Pullback in BioMarin Pharmaceutical Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
BioMarin Pharmaceutical's Short Interest Falls 3.68% Amid Market Sentiment Shift - AInvest
Should I set a stop loss on BioMarin Pharmaceutical Inc.July 2025 Sector Moves & Free Reliable Trade Execution Plans - sundaytimes.kr
Technical signs of recovery in BioMarin Pharmaceutical IncMarket Sentiment Review & Weekly Consistent Profit Watchlists - Newser
Biomarin Pharmaceutical Inc Azioni (BMRN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):